Fluorine-18 patents (2009–2015). Part 2: new radiochemistry-Reference-Cited by-同舟云学术

Fluorine-18 patents (2009–2015). Part 2: new radiochemistry

Published:2016-09 Issue:5 Volume:5 Page:319-349
ISSN:2046-8954
Container-title:Pharmaceutical Patent Analyst
language:en
Short-container-title:Pharmaceutical Patent Analyst

Author:

Mossine Andrew V¹,Thompson Stephen¹,Brooks Allen F¹,Sowa Alexandra R²,Miller Jason M²,Scott Peter JH¹²

Affiliation:

1. Department of Radiology, University of Michigan Medical School, 1301 Catherine St., Ann Arbor, MI 48109, USA

2. Department of Medicinal Chemistry, University of Michigan, 428 Church St., Ann Arbor, MI 48109, USA

Abstract

Fluorine-18 (18F) is one of the most common positron-emitting radionuclides used in the synthesis of positron emission tomography radiotracers due to its ready availability, convenient half-life and outstanding imaging properties. In Part 1 of this review, we presented the first analysis of patents issued for novel radiotracers labeled with fluorine-18. In Part 2, we follow-up with a focus on patents issued for new radiochemistry methodology using fluorine-18 issued between January 2009 and December 2015.

Publisher

Future Science Ltd

Subject

General Medicine

Link

http://www.future-science.com/doi/pdf/10.4155/ppa-2016-0028

Reference153 articles.

1. IMV Medical Information Division. 2014 PET imaging market summary report. IMV, IL, USA, 60018 (2014).

2. Applications of Fluorine in Medicinal Chemistry

3. Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)

4. Fluorine-18 patents (2009–2015). Part 1: novel radiotracers

5. Synthesis of11C,18F,15O, and13N Radiolabels for Positron Emission Tomography

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiochemistry for positron emission tomography;Nature Communications;2023-06-05

2. Optimization of Precursor Synthesis Conditions of (2S,4S)4–[18F]FPArg and Its Application in Glioma Imaging;Pharmaceuticals;2022-07-29

3. Carbon-11 patents (2012–2022): synthetic methodologies and novel radiotracers for PET imaging;Expert Opinion on Therapeutic Patents;2022-04-28

4. Synthetic methodologies and PET imaging applications of fluorine-18 radiotracers: a patent review;Expert Opinion on Therapeutic Patents;2022-01-28

5. PET Radiopharmaceutical Development;Hybrid PET/MR Neuroimaging;2021-11-30